XTL BIOPHARMACEUTICALS LTD. Insurance Finance Income Expenses
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Insurance Finance Income Expenses of $572.00 thousand for the 3-month period ending 2022-06-30, per its 6-K filed 2022-08-24.
Discontinued › Operating Expenses
ifrs-full:InsuranceFinanceIncomeExpenses · last filed 2022-08-24
- XTL BIOPHARMACEUTICALS LTD. insurance finance income expenses for the quarter ending 2022-06-30 was $572.00K.
| Period end | Insurance Finance Income Expenses 3 month | Insurance Finance Income Expenses 6 month |
|---|---|---|
| 2022-06-30 | $572.00K 6-K · filed 2022-08-24 | $348.00K 6-K · filed 2022-08-24 |